Cytologic evidence of malignancy on smear of vagina
ICD-10 R87.624 is a billable code used to indicate a diagnosis of cytologic evidence of malignancy on smear of vagina.
Cytologic evidence of malignancy on smear of vagina refers to the identification of cancerous cells in a vaginal smear test, which is often performed as part of routine gynecological examinations. This finding indicates the presence of abnormal cells that may suggest a malignancy, such as cervical cancer or other forms of gynecological cancers. The smear test, commonly known as a Pap test, is crucial for early detection of precancerous changes and malignancies in the cervical and vaginal areas. The presence of malignant cells can be associated with various symptoms, including abnormal vaginal bleeding, unusual discharge, or pelvic pain. It is essential for healthcare providers to follow up on these findings with further diagnostic procedures, such as colposcopy or biopsy, to confirm the diagnosis and determine the appropriate treatment plan. Accurate coding of this finding is vital for ensuring proper patient management and for tracking cancer incidence in populations.
Documentation must include detailed cytologic findings, patient history, and any follow-up actions taken.
Patients presenting with abnormal vaginal bleeding or discharge who undergo Pap smears.
Consider the patient's age, risk factors, and previous Pap results for accurate coding.
Acute care documentation should include immediate symptoms, cytologic findings, and any urgent interventions.
Patients with acute pelvic pain or bleeding requiring immediate evaluation.
Emergency settings may require rapid assessment and documentation of findings for timely treatment.
Used when a Pap smear is performed and cytologic evidence of malignancy is found.
Document the type of smear, findings, and any follow-up recommendations.
Ensure that the procedure is linked to the diagnosis for accurate billing.
R87.624 indicates that a Pap smear has shown cytologic evidence of malignancy, which is critical for early detection and management of potential cancers.
